SPDR Portfolio Europe ETF

HSBC holds Asia summit in Hong Kong to showcase three business pillars

China Leverages New Energy Exports to Counter Economic Risks; HSBC Launches Fund as EU Considers Reducing Dependence

HSBC: Low Financing Dependence and High Deposit-Lending Ratio Grant Flexibility and Growth Potential

HSBC: AI to Reshape Finance Jobs, Group Retraining Staff to Adapt

HSBC CEO Announces Takeover of Hang Seng and Major Cost Cuts to Drive Growth

HSBC Unveils Business Strategy Update: Cuts 300 MDs in a Year, Reduces Headcount by 4,400 to Save $600M

French Anti-Fraud Officials Raid Nestle's Perrier Plant Amid Fraud Probe

HSBC Opens Fifth Wealth Centre Aiming to Become Asia's Largest Wealth Manager

HSBC Opens 4th Wealth & Health Center, Expands Mainland Medical Partnerships for High-Net-Worth Clients

HSBC prices 1.4 billion AUD senior unsecured kangaroo bonds

HSBC Holdings Raises AUD 1.4 Billion via Three-Part Kangaroo Bond Deal

HSBC Opens 5th Premier Wealth Centre in Hong Kong, Appointments Fully Booked

HSBC Holdings launches benchmark AUD bond issuance

HSBC Holdings Issues Perpetual Subordinated Contingent Convertible Securities

TotalEnergies Executive Jean Pierre Sbraire Offloads Shares Worth ~912k EUR OTC

HSBC Premier Launches First Cross-Border Health Ecosystem Covering HK and Mainland

AstraZeneca and Daiichi Sankyo's Enhertu Approved by FDA for HER2+ Early Breast Cancer

AstraZeneca's Baxfendy Approved in US, Outpacing Mineralys Therapeutics

AstraZeneca and Roche Diagnostics APAC Partner to Develop Advanced Pathology Solutions for Breast and Lung Cancer

TotalEnergies Visits GCL Photonics to Deepen Perovskite Global Cooperation

Agape ATP

Akanda

Co-Diagnostics

PicoCELA

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Tradr 2X Long RGTI Daily ETF

Liminatus Pharma

Netcapital

EVAX

SAPH

SPEU

European equities traded in the US saw a rise in American depositary receipts, increasing 0.78% to 1,826.25 on the S&P Europe Select ADR Index, up 1.3% for the week. Notable gainers included Nokia (4.7%) and Evaxion (4.4%), while SAP (-1.6%) and Sequans Communications (-1.2%) were among the decliners. In the UK, Lloyds Banking Group rose 3%, while Biodexa Pharmaceuticals fell 4.9%.

Fidelity

Nokia Oyj

Evaxion A/S

SAP SE

SAP SE ADRhedged

European Equities Traded in the US as American Depositary Receipts Rise Friday

DBVT

MREO

BCYC

CLLS

European equities traded in the US as American depositary receipts rose 1.17% to 1,758.40 on the S&P Europe Select ADR Index. Notable gainers included Cellectis (CLLS) and DBV Technologies (DBVT), up 5.1% and 3.1%, respectively. ING Groep (ING) and Banco Santander (SAN) also saw increases of 2.8% and 2.1%. Decliners included Equinor (EQNR) and Eni (E), down 5.1% and 2.9%. UK gainers were led by Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), while BP and British American Tobacco were among the decliners.

fidelity

DBV Tech

First Trust STOXX EUROPE

Mereo Biopharma

Bicycle Therapeutics

BP PLC-Spons

Cellectis

ING Groep

European Equities Traded in the US as American Depositary Receipts Rising Sharply in Wednesday Trading

NVOX

DAVA

AKTX

EDAP

European equities traded in the US saw a decline of 0.56% on the S&P Europe Select ADR Index, reaching 1,718.19, though still up 0.2% for the week. Notable gainers included EDAP TMS (+4.2%) and Novo Nordisk (+2.6%), while Banco Santander (-1.6%) and Cellectis (-1.2%) were among the decliners from continental Europe. In the UK, Akari Therapeutics (+3.2%) and Endava (+3.1%) led the gains, while Silence Therapeutics (-4.9%) and Lloyds Banking Group (-1.5%) were the top decliners.

Defiance Daily Target 2X Long NVO ETF

Endava

Akari Therap

Banco Santander SA-Spon

Novo Nordisk AS

Lloyds Banking

EDAP TMS

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

In trading on Wednesday, shares of the SPDR Portfolio Europe ETF (SPEU) crossed above their 200-day moving average of $50.80, reaching a high of $51.09 per share. Currently, SPEU shares are up about 1.4% for the day. The ETF's 52-week range shows a low of $38.99 and a high of $56.455, with the last trade at $50.85.

nasdaq

SPEU Crosses Above Key Moving Average Level

NCNA

BDRX

European equities traded in the US saw a rise in American depositary receipts, increasing 1.39% to 1,731.11 on the S&P Europe Select ADR Index. Notable gainers included DBV Technologies (4.5%) and Evaxion (3.2%), while decliners were led by Natuzzi (-6.3%) and EDAP TMS (-4.7%). UK gainers included Biodexa Pharmaceuticals (6%) and Silence Therapeutics (5%), with NuCana (-1.9%) and Pearson (-0.7%) as the only decliners from the UK and Ireland.

Nucana

Natuzzi SPA

Biodexa Pharmaceuticals

Pearson PLC

Pearson

Silence Therapeutics

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading

EQNR

EIPAF

European equities traded in the US saw a decline in American depositary receipts, with the S&P Europe Select ADR Index falling 0.5% to 1,711.73. Notable gainers included Equinor (8.5%) and Eni (3.2%), while Banco Santander (-2.8%) and Grifols (-3.1%) were among the decliners. In the UK, BP rose 4.3% and Amarin 1.3%, whereas Biodexa Pharmaceuticals fell 9.8% and NuCana 3.5%.

Equinor Asa

Eni Spa-Sponsored

Equinor ASA

Amarin

GRIFOLS SA

BP p.l.c. ADRhedged

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

ABVX

European equities traded in the US as American depositary receipts rose 1.7% to 1,741.84 on the S&P Europe Select ADR Index. Notable gainers included Turbo Energy (TURB) up 7.5%, Abivax (ABVX) up 5.7%, and Nokia (NOK) up 4.3%. Decliners included Evaxion (EVAX) down 7.3%, Cadeler (CDLR) down 4%, and DBV Technologies (DBVT) down 0.8%. From the UK and Ireland, Silence Therapeutics (SLN) rose 5.9% and Carnival (CUK) rose 3.8%, while Akari Therapeutics (AKTX) fell 7.7% and Biodexa Pharmaceuticals (BDRX) fell 4%.

Carnival

Abivax SA

Carnival plc

European Equities Traded in the US as American Depositary Receipts Higher Monday

BNTX

TRIB

European equities traded in the US as American depositary receipts rose 1.12% to 1,777.07 on the S&P Europe Select ADR Index. Notable gainers included Evaxion (8.4%) and Cellectis (5.6%), while decliners included BioNTech (-21%) and Natuzzi (-18%). From the UK and Ireland, Akari Therapeutics (6.6%) and NuCana (5.1%) led the gains, whereas Trinity Biotech (-8.1%) and Endava (-4%) were the biggest decliners.

BioNTech SE

Trinity Biotech

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

SQNS

ASND

MTLS

European equities traded in the US saw a slight increase, with the S&P Europe Select ADR Index rising 0.1% to 1,845.20, marking a 1.76% gain for the week. Notable gainers included Sequans Communications and DBV Technologies, while Ascendis Pharma and Materialise were among the decliners. In the UK and Ireland, Diageo and Endava led the gains, whereas Biodexa Pharmaceuticals and Trinity Biotech experienced significant declines. MT Newswires does not provide investment advice.

Sequans Comm 

Diageo

Ascendis Pharmac

Materialise

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday trading

SPDR Portfolio Europe ETF(SPEU.US)

European Equities Traded in the US as American Depositary Receipts Rise Friday

European Equities Traded in the US as American Depositary Receipts Rising Sharply in Wednesday Trading

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

SPEU Crosses Above Key Moving Average Level

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading